MedPath

Remission maintenance treatment of ulcerative colitis with tacrolimus in azathioprine-intolerant patients: a randomized comparative trial of 5-aminosalicylic acid (5-ASA) monotherapy versus 5-ASA and tacrolimus combination therapy.

Phase 3
Conditions
lcerative colitis
Registration Number
JPRN-UMIN000003785
Lead Sponsor
Department of Internal medicine, Division of Lower Gastroenterology, Hyogo College of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

1.A patient who has had hypersensitivity to tacrolimus or ingredients of tacrolimus formulation. 2.A patient who is in treatment of cyclosporine or bozentan. 3.A patient who is in treatment of potassium sparing diuretics. 4.A patient who is pregnant, may be pregnant, breast-feeds or hopes to be pregnant in the study period. 5.A patient who is determined as ineligible for a subject in this study by a doctor in charge or others.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath